Medicare Enrolled
Dr. Martin Goldstein, MD
Urology Physician · Maywood, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Goldstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goldstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Goldstein
Dr. Martin Goldstein is an urology physician in Maywood, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Goldstein performed 11,639 Medicare services across 5,001 unique beneficiaries.
Between the years covered by Open Payments, Dr. Goldstein received a total of $4,373 from 32 pharmaceutical and/or device companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Goldstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in NJ
$4,373 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,639
Medicare services
Top 8% in NJ for urology physician
5,001
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~582 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 4,100 | $2 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,149 | $68 | $188 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
873 | $92 | $399 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
870 | $11 | $317 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
664 | $101 | $274 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
643 | $9 | $115 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
634 | $8 | $15 |
| PSA test (prostate cancer screening) | 568 | $18 | $76 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
559 | $3 | $11 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
138 | $214 | $890 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
133 | $8 | $33 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
133 | $8 | $34 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
132 | $0 | $2 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
99 | $74 | $1,459 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
93 | $125 | $412 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
80 | $272 | $1,143 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 76 | $135 | $413 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
67 | $8 | $13 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
62 | $8 | $33 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
60 | $0 | $2 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
52 | $5 | $21 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
52 | $4 | $17 |
| Injection, garamycin, gentamicin, up to 80 mg | 52 | $2 | $3 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
43 | $87 | $236 |
| Ultrasound of abdomen and pelvis blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis. |
42 | $130 | $525 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
39 | $18 | $76 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
39 | $13 | $72 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
34 | $153 | $366 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
32 | $31 | $121 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
28 | $20 | $300 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
26 | $217 | $1,443 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
26 | $128 | $340 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
17 | $25 | $106 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
13 | $8 | $32 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
11 | $29 | $479 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,373
Total received (2018-2024)
Avg $625/year across 7 years
Top 31% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
123
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,345 (53.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,500 (34.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$528 (12.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$150
2023
$167
2022
$256
2021
$829
2020
$1,739
2019
$655
2018
$576
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Davol Inc.
$51
Tolmar, Inc.
$31
Ferring Pharmaceuticals Inc.
$26
Sumitomo Pharma America, Inc.
$25
Calyxo, Inc.
$17
Top 3 companies account for 72.0% of 2024 payments
All-time payments by company (2018-2024) ›
UROGEN PHARMA, INC.
$1,697
Astellas Pharma US Inc
$746
Allergan Inc.
$201
Janssen Biotech, Inc.
$126
Boston Scientific Corporation
$120
Shire North American Group Inc
$119
PFIZER INC.
$112
Laborie Medical Technologies Corp.
$103
KOELIS Inc.
$99
Blue Earth Diagnostics Limited
$98
Endo Pharmaceuticals Inc.
$90
TOLMAR Pharmaceuticals, Inc.
$88
Myovant Sciences Inc.
$78
Bayer HealthCare Pharmaceuticals Inc.
$77
NeoTract Inc.
$68
Calyxo, Inc.
$62
Dendreon Pharmaceuticals LLC
$57
Davol Inc.
$51
AbbVie, Inc.
$46
UROVANT SCIENCES INC
$44
Ferring Pharmaceuticals Inc.
$40
Metuchen Pharmaceuticals
$37
Tolmar, Inc.
$31
Varian Medical Systems, Inc.
$30
Avadel Specialty Pharmaceuticals, LLC
$29
Sumitomo Pharma America, Inc.
$25
UroGen Pharma, Inc.
$21
Olympus America Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$19
Verity Pharmaceuticals Inc.
$14
BOSTON SCIENTIFIC CORPORATION
$13
MEDIVATION FIELD SOLUTIONS LLC
$13
Top 3 companies account for 60.5% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AVEED · Axumin · BOTOX · BOTOX THERAPEUTIC · CINRYZE · CLENPIQ · CVAC ASPIRATION SYSTEM · Channel Drain · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL MALE SUI · Halcyon · JELMYTO · LITHOVUE · Lupron · MYRBETRIQ · Myrbetriq · Noctiva · Nubeqa · ORGOVYX · PROVENGE · REZUM · SOLYX · Stendra · TOVIAZ · Trelstar · Trinity 3D Prostate Suite · UroLift · XIAFLEX · XTANDI · Xofigo · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (54%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
726
Per 100K population
76.0
County median income
$123,715
Nearest hospital
HACKENSACK UNIVERSITY MEDICAL CENTER
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Goldstein is a clinical cardiology specialist, with above-average Medicare volume (top 8% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Goldstein experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Goldstein performed 4,100 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goldstein receive payments from pharmaceutical companies?
Yes. Dr. Goldstein received a total of $4,373 from 32 companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goldstein's costs compare to other urology physicians in Maywood?
Dr. Goldstein's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goldstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Maywood
Browse urology physicians in Maywood ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
UROGEN PHARMA, INC. Payments to Doctors
See all physicians who received payments from UROGEN PHARMA, INC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology